Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
NACLC 2019
2019 North American Conference on Lung Cancer
(Chicago, IL, USA): October 10 – 12, 2019
The NACLC 2019 Virtual Meeting will be composed of the PowerPoint slides of the presentations only.Presentation Date(s):- October 10 – 12, 2019
- Total Presentations: 125
-
+
GS04 - Patient Selection for Local Therapies in the Era of Immunotherapy
- Type: Invited Speaker Session
- Track:
- Presentations: 7
- Slides Available
- Coordinates: 10/11/2019, 10:15 - 11:15, Rouge (Lobby Level)
-
+
GS04.06 - Assessment and Management of IO Toxicity in Combined Modality Trials (Slides Available)
10:52 - 11:00 | Presenter: Mary Fidler
- Abstract
No abstract available for this presentation
-
+
OA01 - Precision Medicine and Personalized Therapy for Lung Cancer
- Type: Oral Abstract Session
- Track:
- Presentations: 11
- Slides Available
- Coordinates: 10/11/2019, 14:00 - 15:40, Imperial Ballroom (B2 Level)
-
+
OA01.02 - Prognostic Value of Baseline Autoantibodies in Metastatic NSCLC Patients Receiving PD-/PDL-1 Targeted Immunotherapy (Slides Available)
14:07 - 14:14 | Presenter: Imad Tarhoni
- Abstract
Loading...
-
+
P1 - Poster Viewing
- Type: Poster Session
- Track:
- Presentations: 22
- Coordinates: 10/11/2019, 16:45 - 18:00, Exhibit Hall
-
+
P1.02 - Chemotherapy with VMAT (Volumetric Modulated Arc Therapy) Radiation Therapy for Poor Risk Stage IIIA-C NSCLC Patients
16:45 - 18:00 | Presenter: Yu Zhou
- Abstract
Loading... -
+
P1.05 - Clinical Factors Associated with Progression in Previously Treated Patients with Metastatic NSCLC on Anti-PD-1 Therapy
16:45 - 18:00 | Presenter: Megan Randall
- Abstract
Loading... -
+
P1.21 - RNA Pathway Enrichment in Serum Based Mass Spectroscopy Prognostic Analyses.
16:45 - 18:00 | Presenter: Mary Fidler
- Abstract
Loading...
-
+
OA03 - IO Concerns and Targeted Therapies
- Type: Oral Abstract Session
- Track:
- Presentations: 10
- Slides Available
- Coordinates: 10/12/2019, 09:45 - 11:15, Rouge (Lobby Level)
-
+
OA03.01 - Biomarkers of Autoimmune Toxicity in Metastatic SCLC Patients Receiving PD-1/PDL-1 Targeted Therapy (Slides Available)
09:45 - 09:52 | Author(s): Imad Tarhoni
- Abstract
Loading...